PCSK9 inhibitors have anti-inflammatory activity assessed by 1H-NMR glycoprotein profile in subjects at high or very high cardiovascular risk
| Autor: | Rehues, P., Girona, J., Guardiola, M., Plana, N., Scicali, R., Piro, S., Muñíz-Grijalvo, O., Díaz-Díaz, J.L., Recasens, L., Pinyol, M., Rosales, R., Esteban, Y., Amigó, N., Masana, L., Ibarretxe, D., Ribalta, J. |
|---|---|
| Zdroj: | In Atherosclerosis August 2023 379 Supplement 1:S70-S70 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect